Does IGF-I therapy in insulin-dependent diabetes mellitus limit complications?
- 1 October 1997
- journal article
- editorial
- Published by Elsevier in The Lancet
- Vol. 350 (9086), 1188-1189
- https://doi.org/10.1016/s0140-6736(97)22043-x
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Essential Role of Growth Hormone in Ischemia-Induced Retinal NeovascularizationScience, 1997
- Metabolic effects of growth hormone in humansMetabolism, 1995
- Adverse Effects of Recombinant Human Insulin-like Growth Factor I in Obese Insulin-Resistant Type II Diabetic PatientsDiabetes, 1994
- Growth During Childhood and Final Height in Type 1 DiabetesDiabetic Medicine, 1994
- Vitreous levels of the insulin-like growth factors I and II, and the insulin-like growth factor binding proteins 2 and 3, increase in neovascular eye disease. Studies in nondiabetic and diabetic subjects.JCI Insight, 1993
- Insulin-like growth factor I acts as an angiogenic agent in rabbit cornea and retina: comparative studies with basic fibroblast growth factorDiabetologia, 1993
- Long-term follow-up of patients who underwent yttrium-90 pituitary implantation for treatment of proliferative diabetic retinopathyDiabetologia, 1987
- Effect of Diabetes and its Control on Insulin-like Growth Factors in the Young Subject with Type I DiabetesDiabetes, 1984
- Insulin-like Growth FactorsNew England Journal of Medicine, 1983
- Diurnal patterns of blood glucose, serum free fatty acids, insulin, glucagon and growth hormone in normals and juvenile diabeticsDiabetologia, 1970